Atopic dermatitis in children

Journal of Allergy and Clinical Immunology: In Practice

Volumn 2, Issue 4, 2014, Pages 388-395

  Arkwright, Peter D ^a   Stafford, Judith C ^a   Sharma, Vibha ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

AD; Atopic dermatitis; Food allergy; Hyper IgE syndrome; MRSA; Staphylococcus aureus; Zinc

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CHLORHEXIDINE; CLINDAMYCIN; CLOBETASONE BUTYRATE; CORTICOSTEROID; IMMUNOGLOBULIN E; IRON; METICILLIN; OMALIZUMAB; VIRULENCE FACTOR; ZINC;

ALLERGIC ASTHMA; ALLERGY TEST; ARTICLE; ATOPIC DERMATITIS; BACTERIAL LOAD; BACTERIUM ISOLATION; CAREGIVER; CASE REPORT; CHILD; COGNITIVE THERAPY; DAIRY PRODUCT; DERMATOPHAGOIDES; DISEASE SEVERITY; ECZEMA; EGG; FAMILY HISTORY; FEMALE; FOOD ALLERGY; GENE MUTATION; HUMAN; IMMUNOTHERAPY; IRON BLOOD LEVEL; LABORATORY TEST; MENTAL STRESS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MILK; NUTRITIONAL STATUS; OBSESSIVE COMPULSIVE DISORDER; PATIENT EDUCATION; PERENNIAL RHINITIS; POLYMERASE CHAIN REACTION; PSYCHOLOGICAL ASPECT; RHINOCONJUNCTIVITIS; SCHOOL CHILD; SKIN INFECTION; SOCIAL ASPECT; TREATMENT FAILURE; TREATMENT OUTCOME; VESICULAR RASH; WEIGHT GAIN; WELLBEING; WHEAT; ZINC BLOOD LEVEL; ANIMAL; BLOOD; COMPLICATION; DERMATITIS, ATOPIC; DESENSITIZATION; FEEDING BEHAVIOR; IMMUNOLOGY; MICROBIOLOGY; OBSESSIVE-COMPULSIVE DISORDER; PATHOLOGY; PROCEDURES; PYROGLYPHIDAE; QUALITY OF LIFE; SKIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUBLINGUAL DRUG ADMINISTRATION;

ADMINISTRATION, SUBLINGUAL; ANIMALS; ANTI-BACTERIAL AGENTS; CHILD; COGNITIVE THERAPY; DERMATITIS, ATOPIC; DESENSITIZATION, IMMUNOLOGIC; FEMALE; FOOD HABITS; HUMANS; IMMUNOGLOBULIN E; OBSESSIVE-COMPULSIVE DISORDER; PYROGLYPHIDAE; QUALITY OF LIFE; SKIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84904068595     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2014.01.016     Document Type: Article

References (51)

1. Schlievert P.M., Strandberg K.L., Lin Y.C., Peterson M.L., Leung D.Y. Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. JAllergy Clin Immunol 2010, 125:39-49.
2. Bergman M.M., Caubet J.C., Boguniewicz M., Eigenmann P.A. Evaluation of food allergy in patients with atopic dermatitis. JAllergy Clin Immunol Pract 2013, 1:22-28.
3. Fleischer D.M., Bock S.A., Spears G.C., Wilson C.G., Miyazawa N.K., Gleason M.C., et al. Oral food challenges in children with a diagnosis of food allergy. JPediatr 2011, 158:578-583.
4. Zhang Q., Su H.C. Hyperimmunoglobulin E syndromes in pediatrics. Curr Opin Pediatr 2011, 23:653-658.
5. Woellner C., Gertz E.M., Schäffer A.A., Lagos M., Perro M., Glocker E.O., et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. JAllergy Clin Immunol 2010, 125:424-432.
6. Zhang Q., Davis J.C., Lamborn I.T., Freeman A.F., Jing H., Favreau A.J., et al. Combined immunodeficiency associated with DOCK8 mutations. NEngl J Med 2009, 361:2046-2055.
7. Pellicano R., De Angelis C., Ribaldone D.G., Fagoonee S., Astegiano M. 2013 update on celiac disease and eosinophilic esophagitis. Nutrients 2013, 5:3329-3336.
8. Ciacci C., Cavallaro R., Iovino P., Sabbatini F., Palumbo A., Amoruso D., et al. Allergy prevalence in adult celiac disease. JAllergy Clin Immunol 2004, 113:1199-1203.
9. Spergel J.M., Brown-Whitehorn T.F., Beausoleil J.L., Shuker M., Wang M.L., Verma R., et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. JPediatr Gastroenterol Nutr 2009, 48:30-36.
10. Gehrig K.A., Dinulos J.G. Acrodermatitis due to nutritional deficiency. Curr Opin Pediatr 2010, 22:107-112.
11. Krejci-Manwaring J., Tusa M.G., Carroll C., Camacho F., Kaur M., Carr D., et al. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. JAm Acad Dermatol 2007, 56:211-216.
12. Santer M., Burgess H., Yardley L., Ersser S., Lewis-Jones S., Muller I., et al. Experiences of carers managing childhood eczema and their views on its treatment: a qualitative study. Br J Gen Pract 2012, 62:e261-e267.
13. Fenerty S.D., O'Neill J.L., Gustafson C.J., Feldman S.R. Maternal adherence factors in the treatment of pediatric atopic dermatitis. JAMA Dermatol 2013, 149:229-231.
14. Kojima R., Fujiwara T., Matsuda A., Narita M., Matsubara O., Nonoyama S., et al. Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr Dermatol 2013, 30:29-35.
15. Smith S.D., Stephens A.M., Werren J.C., Fischer G.O. Treatment failure in atopic dermatitis as a result of parental health belief. Med J Aust 2013, 199:467-469.
16. Irvine A.D., McLean W.H., Leung D.Y. Filaggrin mutations associated with skin and allergic diseases. NEngl J Med 2011, 365:1315-1327.
17. Kaae J., Menné T., Carlsen B.C., Zachariae C., Thyssen J.P. The hands in health and disease of individuals with filaggrin loss-of-function mutations: clinical reflections on the hand eczema phenotype. Contact Dermatitis 2012, 67:119-124.
18. Gao P.S., Rafaels N.M., Hand T., Murray T., Boguniewicz M., Hata T., et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. JAllergy Clin Immunol 2009, 124:507-513.
19. Anderson P.C., Dinulos J.G. Atopic dermatitis and alternative management strategies. Curr Opin Pediatr 2009, 21:131-138.
20. Zuberbier T., Orlow S.J., Paller A.S., Taïeb A., Allen R., Hernanz-Hermosa J.M., et al. Patient perspectives on the management of atopic dermatitis. JAllergy Clin Immunol 2006, 118:226-232.
21. Cork M.J., Britton J., Butler L., Young S., Murphy R., Keohane S.G. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 2003, 149:582-589.
22. Ellison J.A., Patel L., Ray D.W., David T.J., Clayton P.E. Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis. Pediatrics 2000, 105:794-799.
23. van Velsen S.G., Knol M.J., van Eijk R.L., de Vroede M.A., de Wit T.C., Lam M.G., et al. Bone mineral density in children with moderate to severe atopic dermatitis. JAm Acad Dermatol 2010, 63:824-831.
24. Carr W.W. Topical calcineurin inhibitors for atopic dermatitis: review and treatment recommendations. Paediatr Drugs 2013, 15:303-310.
25. Arana A., Wentworth C.E., Fernández-Vidaurre C., Schlienger R.G., Conde E., Arellano F.M. Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K. Br J Dermatol 2010, 163:1036-1043.
26. Arellano F.M., Arana A., Wentworth C.E., Fernández-Vidaurre C., Schlienger R.G., Conde E. Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom. JAllergy Clin Immunol 2009, 123:1111-1116.
27. Mediavilla J.R., Chen L., Mathema B., Kreiswirth B.N. Global epidemiology ofcommunity-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Curr Opin Microbiol 2012, 15:588-595.
28. Balma-Mena A., Lara-Corrales I., Zeller J., Richardson S., McGavin M.J., Weinstein M., et al. Colonization with community-acquired methicillin-resistant Staphylococcus aureus in children with atopic dermatitis: a cross-sectional study. Int J Dermatol 2011, 50:682-688.
29. Matiz C., Tom W.L., Eichenfield L.F., Pong A., Friedlander S.F. Children with atopic dermatitis appear less likely to be infected with community acquired methicillin-resistant Staphylococcus aureus: the San Diego experience. Pediatr Dermatol 2011, 28:6-11.
30. Petry V., Lipnharski C., Bessa G.R., Silveira V.B., Weber M.B., Bonamigo R.R., et al. Prevalence of community-acquired methicillin-resistant Staphylococcus aureus and antibiotic resistance in patients with atopic dermatitis in Porto Alegre, Brazil. Int J Dermatol 2013, Oct 29.
31. Hill S.E., Yung A., Rademaker M. Prevalence of Staphylococcus aureus and antibiotic resistance in children with atopic dermatitis: a New Zealand experience. Australas J Dermatol 2011, 52:27-31.
32. Arkwright P.D., Daniel T.O., Sanyal D., David T.J. Age-related prevalence and antibiotic resistance of pathogenic staphylococci and streptococci in children with infected atopic dermatitis at a single-specialty center. Arch Dermatol 2002, 138:939-941.
33. Huang J.T., Abrams M., Tlougan B., Rademaker A., Paller A.S. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009, 123:e808-e814.
34. Aronson P.L., Yan A.C., Mittal M.K., Mohamad Z., Shah S.S. Delayed acyclovir and outcomes of children hospitalized with eczema herpeticum. Pediatrics 2011, 128:1161-1167.
35. Gilani S.J., Gonzalez M., Hussain I., Finlay A.Y., Patel G.K. Staphylococcus aureus re-colonization in atopic dermatitis: beyond the skin. Clin Exp Dermatol 2005, 30:10-13.
36. Gordon-Elliott J.S., Muskin P.R. Managing the patient with psychiatric issues in dermatologic practice. Clin Dermatol 2013, 31:3-10.
37. Gupta M.A., Gupta A.K. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol 2003, 4:833-842.
38. Ellis R.M., Koch L.H., McGuire E., Williams J.V. Potential barriers to adherence in pediatric dermatology. Pediatr Dermatol 2011, 28:242-244.
39. Ersser S.J., Latter S., Sibley A., Satherley P.A., Welbourne S. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev 2007, 18(3):CD004054.
40. Santer M., Burgess H., Yardley L., Ersser S.J., Lewis-Jones S., Muller I., et al. Managing childhood eczema: qualitative study exploring carers' experiences of barriers and facilitators to treatment adherence. JAdv Nurs 2013, 69:2493-2501.
41. Sowden J.M., Berth-Jones J., Ross J.S., Motley R.J., Marks R., Finlay A.Y., et al. Double-bind, controlled, crossover study of ciclosporin in adults with severe refractory atopic dermatitis. Lancet 1991, 338:137-140.
42. Beaumont D.R., Arkwright P.D. Factors determining the effectiveness of oral ciclosporin in the treatment of severe childhood atopic dermatitis. JDermatolog Treat 2012, 23:318-322.
43. Maurer M., Rosén K., Hsieh H.J. Omalizumab for chronic urticaria. NEngl J Med 2013, 368:2530.
44. Iyengar S.R., Hoyte E.G., Loza A., Bonaccorso S., Chiang D., Umetsu D.T., et al. Immunologic effects of omalizumab in children with severe refractory atopic dermatitis: a randomized, placebo-controlled clinical trial. Int Arch Allergy Immunol 2013, 162:89-93.
45. Pajno G.B., Caminiti L., Vita D., Barberio G., Salzano G., Lombardo F., et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. JAllergy Clin Immunol 2007, 120:164-170.
46. Bae J.M., Choi Y.Y., Park C.O., Chung K.Y., Lee K.H. Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials. JAllergy Clin Immunol 2013, 132:110-117.
47. He R., Oyoshi M.K., Garibyan L., Kumar L., Ziegler S.F., Geha R.S. TSLP acts on infiltrating effector T cells to drive allergic skin inflammation. Proc Natl Acad Sci U S A 2008, 105:11875-11880.
48. Otsuka A., Doi H., Egawa G., Maekawa A., Fujita T., Nakamizo S., et al. Possible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expression. JAllergy Clin Immunol 2014, 133:139-146.
49. Arkwright P.D., Motala C., Subramanian H., Spergel J., Schneider L.C., Wollenberg A. Management of difficult to treat atopic dermatitis for the Atopic Dermatitis Working Group of the Allergic Skin Diseases Committee, of the AAAAI. JAllergy Clin Immunol Pract 2013, 1:142-151.
50. Noerreslet M., Jemec G.B., Traulsen J.M. Involuntary autonomy: patients' perceptions of physicians, conventional medicines and risks in the management of atopic dermatitis. Soc Sci Med 2009, 69:1409-1415.
51. de Waard-van der Spek F.B., Andersen K.E., Darsow U., Mortz C.G., Orton D., Worm M., et al. Allergic contact dermatitis in children: which factors are relevant? (review of the literature). Pediatr Allergy Immunol 2013, 24:321-329.